Hanmi Pharmaceutical resumes supply of suppository fever reducer Suspen

The nation's only suppository fever reducer, which is beneficial for children and elderly patients who are unable to swallow fever reducers has resumed its supply.

Hanmi Pharmaceutical, which decided to discontinue the production of Suspen Complex Suppositories in June, said Wednesday that it has recently completed a contract with HLB Pharmaceutical, the only suppository production contract manufacturer in Korea, to resume the drug’s supply.

The company attributed the decision to three factors:

● Hanmi Pharmaceutical's determination to have “Respecting Humans” as its management philosophy.

● Proactive price cooperation with the contract manufacturer.

● Social demands from the medical community and patients.

According to the company, Hanmi Group Song Young-sook directed a working-group examination for resuming the suppository fever reducer, saying, “Compound suspension suppositories are essential for patients who have difficulty swallowing fever-reducing drugs by mouth. Don't think about making much profit, but find a way to resume production.”

In this process, Hanmi Pharmaceutical and the contract manufacturer agreed on prospective unit price cooperation, and the compound suspension suppositories were distributed again through pharmacies nationwide within the year, it added.

“As a pharmaceutical company with the management philosophy of respecting human beings and creating value, we are proud to have made the final decision for patients. That resulted from seamless communication between the majority shareholders of the founding generation and the working team,” Hanmi Pharmaceutical CEO Park Jae-hyun said. “We will continue to focus on what Hanmi Pharm can do well and what only Hanmi Pharm can do.”

Suspen Complex Suppositories is Hanmi Pharmaceutical's legacy product, launched in 1991. It is an antipyretic and pain reliever targeted at pediatric patients. The product will be redesigned before resuming production and will be available in pharmacies nationwide in November.